在2023/2024和2024/2025赛季住院的患者中,COVID-19临床过程的差异
Robert Flisiak1, Dorota Zarębska-Michaluk2, Michał Brzdęk3,4
1Department of Infectious Diseases and Hepatology, Medical University of Białystok, 15-540 Białystok, Poland.
随着COVID-19的不断发展,最近几季的疾病和死亡率都呈现出较轻的程度. 这一趋势是由像Omicron这样的变体驱动的,表明流行病后的临床过程不那么严重.
科学领域:
- 流行病学 流行病学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 波兰的SARSTer计划跟踪了多个季节的COVID-19住院病例.
- 了解COVID-19的临床演变对于公共卫生战略至关重要.
研究的目的:
- 为了比较2023/2024和2024/2025赛季之间的COVID-19住院治疗的临床表现和结果.
- 评估患者人口统计,疾病严重程度和死亡率的变化.
主要方法:
- 分析了2023/2024年住院的719名患者的临床数据.
- 与在2024/2025年住院的360名患者的数据进行比较.
- 评估住院时间,年龄分布,肺病变,临床改善和死亡率.
主要成果:
- 在这两个时期之间,住院治疗的峰值因季节性转移而变化.
- 2024/2025赛季的老年患者人口统计数据 (68%>70岁) 和较轻的疾病 (19%的肺病变).
- 观察到的显著改善:住院次减少一半,提前出院率增加 (39%),死亡率降低 (4.7%),特别是在老年人 (5.4%).
结论:
- 由Omicron变种引发的较温和COVID-19的趋势持续存在.
- 现实世界的数据显示了COVID-19在后大流行时代的持续演变.
- 这些发现支持COVID-19的不太严重的临床轨迹.
更多相关视频
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
相关概念视频
Stages of Infection
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
